Table 1.
Antibiofilm Agent | Target Pathogen | Antibiofilm Mode of Action | Study Model | Reference |
---|---|---|---|---|
Exopolysaccharide-targeting agents | ||||
Quinoxaline derivative | Streptococcus mutans | Glucosyltransferase inhibitor | Anticaries rat | [41] |
Oxazole derivative | S. mutans | Antagonizing glucosyltransferases | Dental caries rat | [46] |
Dispersin B | Staphylococcus spp. | Inhibited skin colonization, detachment of Staphylococcal cells from skin | In vivo pig model | [47] |
Endolysins | S. aureus | Peptidoglycan hydrolases | System MRSA infection in mice | [48] |
Dornase alfa | Pseudomonas aeruginosa | Dissolving cystic fibrosis sputum and fibrillar structures |
Cystic fibrosis sputum | [49] |
DNABII antibodies | Haemophilus influenzae | Targeting epitopes of DNABII found in extracellular DNA | Chinchilla and murine | [50] |
α-amylase |
S. aureus and P. aeruginosa |
Exopolysaccharide disruption | Danio rerio | [51] |
Biofilm dispersion-targeting agents | ||||
Nitric oxide | P. aeruginosa | Biofilm dispersion Reduced biofilm tolerance to antibiotics |
Cystic fibrosis sputum | [52] |
Cephalosporin-3′-diazeniumdiolates | P. aeruginosa | Biofilm dispersion; increases biofilm susceptibility to antibiotics |
Microtiter plates | [53] |
Nitroxides | P. aeruginosa | Promotes biofilm dispersal, inhibits biofilm formation, increases swarming motility | Flow chambers | [54] |
Autoinducing peptide inhibitor | S. aureus | Quorum sensing inhibitor | RN9222 cell line | [55] |
Natural peptide Capsicumicine | S. epidermidis | Disassembly of biofilm matrix | SKH1 mice | [56] |
Biofilm persister-targeting agents | ||||
TM5 peptide |
P. aeruginosa and S. aureus |
Antipersister agent | Laboratory settings | [57] |
Rifampin + Fosfomycin |
S. aureus (Methicillin-resistant) |
Cure of cage-associated infections | A foreign body infection model using guinea pigs | [58] |
Acyldepsipeptide ADEP4 | S. aureus | Activation of ClpP protease which kills growing and persister cells | Mouse model of a chronic infection | [59] |
Glycosylated cationic peptides |
S. aureus (Methicillin-resistant) |
Bactericidal against persister cells and disperses biofilm mass | Ex vivo wounded human skin infection | [60] |